Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.
暂无分享,去创建一个
[1] H. Käyhty,et al. Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young Children , 2002, Clinical and Vaccine Immunology.
[2] P. Mäkelä,et al. Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media , 2002, The Pediatric infectious disease journal.
[3] J. Eskola,et al. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. , 2001, Vaccine.
[4] J. Eskola,et al. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. , 2001, The Journal of infectious diseases.
[5] H. Pursiainen,et al. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. , 2001, The Journal of infectious diseases.
[6] A. Takala,et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. , 2001, The Journal of infectious diseases.
[7] A. Takala,et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life , 2001, The Pediatric infectious disease journal.
[8] B. Simell,et al. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. , 2001, The Journal of infectious diseases.
[9] S. Lockhart,et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.
[10] J. Eskola,et al. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine , 2001, The Pediatric infectious disease journal.
[11] B. Greenwood,et al. Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children. , 2000, Vaccine.
[12] G. Carlone,et al. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. , 2000, The Journal of infectious diseases.
[13] H. Käyhty,et al. Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific? , 2000, Clinical Diagnostic Laboratory Immunology.
[14] E. Swiatlo,et al. Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae , 2000, Infection and Immunity.
[15] J. Eskola,et al. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. , 2000, Vaccine.
[16] K. Edwards,et al. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. , 1999, The Journal of infectious diseases.
[17] R. Huebner,et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.
[18] I. Jónsdóttir,et al. Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines Protects Mice against Invasive Pneumococcal Infections , 1999, Infection and Immunity.
[19] C. Frasch,et al. Pneumococcal Capsular Polysaccharide Preparations May Contain Non-C-Polysaccharide Contaminants That Are Immunogenic , 1999, Clinical Diagnostic Laboratory Immunology.
[20] I. Kwon,et al. Protective Immunity of Microsphere-Based Mucosal Vaccines against Lethal Intranasal Challenge withStreptococcus pneumoniae , 1999, Infection and Immunity.
[21] D. L. Klein,et al. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. , 1998, Vaccine.
[22] R. Malley,et al. Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. , 1998, The Journal of infectious diseases.
[23] S. Obaro,et al. Carriage of pneumococci after pneumococcal vaccination , 1996, The Lancet.
[24] J. Mcghee,et al. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization. , 1996, Vaccine.
[25] C. Liebeler,et al. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. , 1996, The Journal of infectious diseases.
[26] J. Eskola,et al. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. , 1995, The Journal of infectious diseases.
[27] S. Quataert,et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.
[28] M. Leinonen,et al. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants , 1986, Pediatric infectious disease.
[29] M. Heidelberger. Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antisera. , 1984, Molecular immunology.
[30] C. S. Lin,et al. Capsular polysaccharides of nongroupable streptococci that cross-react with pneumococcal group 19. , 1984, Journal of immunology.
[31] P. Mäkelä,et al. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. , 1984, Pediatrics.
[32] M. Pichichero,et al. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. , 1983, The Journal of allergy and clinical immunology.
[33] R. Douglas,et al. Antibody response to pneumococcal vaccination in children younger than five years of age. , 1983, The Journal of infectious diseases.
[34] A. Husband,et al. Ontogeny of the secretory immune system in man. , 1982, Australian and New Zealand journal of medicine.
[35] G. W. Zoller. Pneumococcal vaccine and otitis media , 1981 .
[36] C. Lee,et al. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. , 1981, Journal of immunology.
[37] M. Pichichero,et al. A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. , 1981, The Journal of clinical investigation.
[38] A. Plebani,et al. Ontogeny of Secretory Immunity: Levels of Secretory IgA and Natural Antibodies in Saliva , 1980, Pediatric Research.
[39] M. Leinonen,et al. PNEUMOCOCCAL VACCINE AND OTITIS MEDIA , 1980, The Lancet.
[40] P. Mäkelä,et al. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. , 1977, Pediatrics.
[41] J. C. Parke,et al. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976). , 1977, The Journal of infectious diseases.
[42] M. Heidelberger,et al. Immunochemical relationships between bacteria belonging to two separate families: pneumococci and Klebsiella. , 1976, Immunochemistry.
[43] J. C. Parke,et al. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. , 1975, The Journal of allergy and clinical immunology.
[44] O. Westphal,et al. Relations between structures of three K polysaccharides of Escherichia coli and cross-reactivity in antipneumococcal sera , 1968, Journal of bacteriology.